CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions	Total	Total Equity	Issued common stock	Common stock held in treasury	Common stock held in treasury Restricted Stock	Capital in excess of par value	Retained earnings		Accumulated other comprehensive income (loss)	Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2020			283,575,876
Beginning Balance, common stock held in treasury (in shares) at Dec. 31, 2020				(44,645,173)
Beginning balance at Dec. 31, 2020		$ 6,724	$ 3	$ (1,834)		$ 2,614	$ 6,296		$ (651)	$ 296
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared		(246)					(162)	[1]		(84)	[1]
Net issuance for executive stock plan (in shares)				89,787
Net issuance for executive stock plan		21		$ 2		19
Net issuance of restricted stock (in shares)					756,402
Net issuance of restricted stock		25			$ 20	5
Acquisition of AKASOL		96								96
Purchase and reclass of noncontrolling interest		(91)				(1)				(90)
Net earnings	$ 537	639					537			102
Other comprehensive income (loss)	100								100
Comprehensive income	733	94								(6)
Spin-Off of PHINIA	0
Ending balance (in shares) at Dec. 31, 2021			283,575,876
Ending Balance, common stock held in treasury (in shares) at Dec. 31, 2021				(43,798,984)
Ending balance at Dec. 31, 2021		7,262	$ 3	$ (1,812)		2,637	6,671		(551)	314
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared		(246)					(161)	[1]		(85)	[1]
Net issuance for executive stock plan (in shares)				181,212
Net issuance for executive stock plan		32		$ 4		28
Net issuance of restricted stock (in shares)					583,021
Net issuance of restricted stock		25			$ 16	9
Purchases of treasury stock (shares)				(6,418,914)
Purchase and reclass of noncontrolling interest		(240)		$ (240)
Purchase/sale of noncontrolling interest		(2)				1				(3)
Net earnings	944	1,026					944			82
Other comprehensive income (loss)	(325)								(325)
Comprehensive income	677	(349)								(24)
Spin-Off of PHINIA	$ 0
Ending balance (in shares) at Dec. 31, 2022	283,575,876		283,575,876
Ending Balance, common stock held in treasury (in shares) at Dec. 31, 2022	(49,453,665)			(49,453,665)
Ending balance at Dec. 31, 2022	$ 7,508	7,508	$ 3	$ (2,032)		2,675	7,454		(876)	284
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared		(225)					(130)	[1]		(95)	[1]
Net issuance for executive stock plan (in shares)				238,708
Net issuance for executive stock plan		14		$ 5		9
Net issuance of restricted stock (in shares)					687,799
Net issuance of restricted stock		23			$ 16	7
Purchases of treasury stock (shares)				(5,264,923)
Purchase and reclass of noncontrolling interest		(177)		$ (177)
Purchase/sale of noncontrolling interest		(15)				(2)				(13)
Net earnings	625	695					625			70
Other comprehensive income (loss)	48								64
Comprehensive income	735	56								(8)
Spin-Off of PHINIA	$ 10	(1,813)					(1,797)		(16)
Ending balance (in shares) at Dec. 31, 2023	283,575,876		283,575,876
Ending Balance, common stock held in treasury (in shares) at Dec. 31, 2023	(53,792,081)			(53,792,081)
Ending balance at Dec. 31, 2023	$ 6,066	$ 6,066	$ 3	$ (2,188)		$ 2,689	$ 6,152		$ (828)	$ 238

[1] Dividends declared relate to BorgWarner common stock.